1-6 of 6
Annamaria Gulla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

Keiji Kurata, Mehmet K. Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3956.
https://doi.org/10.1158/1078-0432.CCR-24-2112
Published: 03 September 2024
View article titled, Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Open the PDF for Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma in another window
Journal Articles

Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2288.
https://doi.org/10.1158/1078-0432.CCR-24-1089
Published: 15 May 2024
View article titled, Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Journal Articles

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

Keiji Kurata, Mehmet K. Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1807–1821.
https://doi.org/10.1158/1078-0432.CCR-22-3668
Published: 01 May 2023
View article titled, BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Open the PDF for BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (5): 1222–1233.
https://doi.org/10.1158/1078-0432.CCR-15-0489
Published: 29 February 2016
View article titled, A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Includes: Supplementary data
Journal Articles

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

Emanuela Leone, Eugenio Morelli, Maria T. Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2096–2106.
https://doi.org/10.1158/1078-0432.CCR-12-3325
Published: 15 April 2013
View article titled, Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth
Open the PDF for Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth in another window
Includes: Supplementary data
Journal Articles

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

Maria T. Di Martino, Emanuela Leone, Nicola Amodio, Umberto Foresta, Marta Lionetti, Maria R. Pitari, Maria E. Gallo Cantafio, Annamaria Gullà, Francesco Conforti, Eugenio Morelli, Vera Tomaino, Marco Rossi, Massimo Negrini, Manlio Ferrarini, Michele Caraglia, Masood A. Shammas, Nikhil C. Munshi, Kenneth C. Anderson, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6260–6270.
https://doi.org/10.1158/1078-0432.CCR-12-1708
Published: 14 November 2012
View article titled, Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence
Open the PDF for Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence in another window
Includes: Supplementary data